- Home
- MCK vs BMY Comparison
MCK vs BMY Comparison
Compare MCK & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCK | BMY |
|---|---|---|
| Founded | 1833 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.5B | 113.5B |
| IPO Year | 1995 | 2006 |
Fundamental Metrics
Financial Performance| Metric | MCK | BMY |
|---|---|---|
| Price | $865.06 | $64.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 15 |
| Target Price | ★ $952.92 | $61.73 |
| AVG Volume (30 Days) | 922.7K | ★ 12.0M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | 0.40% | ★ 4.38% |
| EPS Growth | 49.22 | ★ 178.46 |
| EPS | ★ 5.15 | 2.93 |
| Revenue | ★ $112,084,000,000.00 | $48,194,000,000.00 |
| Revenue This Year | $14.94 | N/A |
| Revenue Next Year | $8.21 | N/A |
| P/E Ratio | $170.63 | ★ $21.74 |
| Revenue Growth | ★ 3.11 | N/A |
| 52 Week Low | $667.50 | $42.52 |
| 52 Week High | $999.00 | $68.10 |
Technical Indicators
Market Signals| Indicator | MCK | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 55.49 | 60.59 |
| Support Level | $799.15 | $56.46 |
| Resistance Level | $900.58 | $68.10 |
| Average True Range (ATR) | 28.39 | 1.78 |
| MACD | -0.09 | -0.20 |
| Stochastic Oscillator | 56.23 | 37.74 |
Price Performance
Historical ComparisonAbout MCK McKesson Corporation
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.